Treating critically ill COVID-19 patients with non-altered umbilical cord stem cells increases survival

By | June 8, 2021
Critically ill COVID-19 patients treated with non-altered stem cells from umbilical cord connective tissue were more than twice as likely to survive as those who did not have the treatment, according to a study published today in STEM CELLS Translational Medicine.